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Abstract
Ras proteins are distributed in distinct plasma-membrane microdomains and endomembranes. The
biochemical signals generated by Ras therein differ qualitatively and quantitatively, but the extent
to which this spatial variability impacts on the genetic program switched-on by Ras is unknown. We
have used microarray technology to identify the transcriptional targets of localization-specific Ras
subsignals in NIH3T3 cells expressing H-RasV12 selectively tethered to distinct cellular
microenvironments. We report that the transcriptomes resulting from site-specific Ras activation
show a significant overlap. However, distinct genetic signatures can also be found for each of the
Ras subsignals. Our analyses unveil 121 genes uniquely regulated by Ras signals emanating from
plasma-membrane microdomains. Interestingly, not a single gene is specifically controlled by lipid
raft-anchored Ras. Furthermore, only 9 genes are exclusive for Ras signals from endomembranes.
Also, we have identified 31 genes common to the site-specific Ras subsignals capable of inducing
cellular transformation. Among these are the genes coding for Vitamin D receptor and for p120-GAP
and we have assessed their impact in Ras-induced transformation. Overall, this report reveals the
complexity and variability of the different genetic programs orchestrated by Ras from its main
sublocalizations.
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1. Introduction
Ras GTPases operate as molecular switches that convey signals from surface receptors to the
interior of the cell, thereby regulating essential processes including proliferation,
differentiation and survival [1]. Ras implication in the origin and progression of pathological
conditions like cancer is also extensively documented [2]. The mechanisms whereby Ras
promotes malignant transformation have been subject of exhaustive cellular and biochemical
studies. Recently, the development of DNA microarray technologies has allowed genome-wide
analyses of the alterations in gene expression profiles resulting from changes in Ras status.
Extensive data has been accumulated on the transcriptional networks associated to the
transformation of different cell lines by oncogenic Ras proteins [3-9]. Likewise, the expression
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profiles resulting from the ablation of H-Ras and N-Ras in murine fibroblasts have also been
reported [10].
Ras proteins are segregated in plasma-membrane (PM) microdomains like lipid rafts and
disordered membrane (DM) [11]. Furthermore, Ras is also present in endomembranes like
endosomes, endoplasmic reticulum (ER) and the Golgi complex, where it can productively
engage downstream effectors [12,13]. The presence of Ras in various compartments could be
intended to generate variability in its biochemical and biological outputs. In support of this
notion, recent findings indicate that the microenvironment in which Ras signals originate
determines effector usage and subsequent biological outcomes [12,14].
Herein, we have extended these observations by analyzing the gene expression profiles
resulting from Ras activity in its main signaling platforms, namely: DM, lipid rafts, Golgi
complex and ER. Our data unveils the existence of distinct transcriptional networks that depend
on the compartment at which Ras signals originate, further endorsing the concept of the
microenvironment as a key regulator of the biochemical, genetic and biological outcomes of
Ras signals. Furthermore, by focusing on the common elements among the transcriptomes of
the site-specific Ras signals capable of inducing transformation, we have identified novel
participants in this phenomenon.
2. Materials and methods
2.1. Microarray experiments and data analysis
Total RNAs from triplicates of exponentially growing NIH3T3 cell lines stably expressing H-
RasV12 and the tethered H-RasV12 proteins [14], were collected using the RNEasy method
(Quiagen). The quantity and quality of the RNAs was determined using 6000 Nano Chips
(Agilent Technologies). RNA samples (4 μg) were processed for hybridization on MGU75Av2
microarrays (Affymetrix) following manufacturer’s recommendations. Normalization,
filtering and analysis of the raw data, was performed using the Bioconductor software
(www.bioconductor.com) using de ReadAffy package and the robust-multiarray analysis
(RMA) application. The RMA algorithm was selected for its precision in signal detection to
achieve adequate normalization of multiple microarrays, especially in cases of low levels of
expression [15]. A gene was considered to be differentially expressed relative to the parental
cell line when exhibiting a signal ≥100 and fulfilling the following criteria: a gene was regarded
as “common” to all Ras mutants when: (i) It showed a fold change ≥±1.5 in all the cell lines
analyzed when compared to the parental cell line; (ii) the fold change values obtained had
statistical P-values ≤0.01. A gene was regarded as differentially expressed in some specific
localization(s) when it did not undergo significant fold changes or when those changes had
P values ≥0.01. A gene was uniquely regulated by a Ras protein when: (i) the fold change in
the expression levels of is transcript in a given localization was ≥±1.5 with P-value P≤0.01;
(ii) the fold change, if any, obtained in the other cell lines had P-values ≤0.01. Statistical
analyses were performed using F-statistics. For the graphical presentation of microarray data,
we performed hierarchical clustering analysis using the WPGA average linkage and the
standard correlation similarity metric method with the J-Express application (2.1). Functional
annotation of gene functions was performed manually using internet-available databases. The
identification of proteins interactive networks was done using the Ingenuity Pathways Analysis
program (www.ingenuity.com). We considered a network significant when it fulfilled the
following criteria: (i) to have a minimal score of 15. (ii) to have at least 20 proteins participating
in direct functional interactions inside the network.
2.2. Cellular transformation assays
Performed exactly as described [14].
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2.3. Antibodies and other reagents
Rabbit polyclonal antibody anti-Vitamin D receptor and the mammalian expression vector
encoding for this receptor were gifts from Dr. Ana Aranda (Madrid, Spain). Rabbit polyclonal
antibodies against p120-GAP, Myc and ERK2 were from Santa Cruz Technologies.
2.4. Immunoblotting
Exactly as described previously [16].
2.5. Real-time PCR
Verification experiments using real-time PCR were performed using a commercial kit
(Quiagen), following manufacturer’s instructions. The PCR primer sets sequences utilized
correspond to those used in the Affymetrix arrays. The housekeeping gene GAPDH was used
as internal control.
3. Results
3.1. Global analysis of Ras site-specific transcriptomes
To conduct this study, we used NIH3T3 cell lines expressing H-RasV12 selectively tethered
to defined subcellular compartments by specific localization signals: the avian infectious
bronchitis virus M1 protein (for ER localization), the LCK myristoylation signal (for lipid raft
anchoring), the CD8α transmembrane domain (for DM localization) and the KDEL receptor
N193D mutant (for Golgi complex localization). The validity of this approach has been
described previously at the cell biology and signaling level [14]. A cell line expressing
untargeted H-RasV12 was also included (see Supplementary Text, Section I). The gene
expression profiles of these cell lines were compared to that of parental NIH3T3 cells, using
Affymetrix microarrays. We observed that, in total, H-RasV12 signals emanating from its
distinct sublocalizations induced changes in 8.8% (1074 genes) of the genes interrogated in
the arrays (Fig. 1A, Supplementary Table S1). Verification by RT-PCR and/or immunoblotting
of 20 randomly chosen samples confirmed the microarray data (data not shown). Hierarchical
clustering of the microarray data sets yielded a dendrogram with two main vertical branches
(Fig 1A): one corresponding to the untethered H-RasV12-dependent transcriptome and the
other one clustering those generated by the site-specific H-RasV12 constructs. Interestingly,
the transcriptome of H-RasV12 at the DM diverged from the expression profiles generated by
H-RasV12 at lipid rafts, ER and the Golgi complex, which were grouped into a separate branch
(Fig 1A). 329 genes were common to all the cases analyzed. Among these, essential genes
involved in the regulation of proliferation and survival such as: PDGFα, TGFβ, FGFr, Integrin
β5, Rho-C, PAK-3, MKK6, PTEN, MKP-1, c-Jun, Jun-B, Fra-1, Cyclin D1 and NFκB
(Supplementary Table S2).
Further analysis of the transcriptomes revealed that the fold changes of the regulated genes
followed a Poisson curve (Fig. 1B). Most of the genes experienced changes between 1.2 and
2.5 fold. Up-regulated and down-regulated genes followed similar patterns. Segregation of the
1074 identified genes into 17 different functional classes revealed that the higher numbers of
genes were involved in transcriptional regulation, metabolism and signal transduction (Fig.
1C) (see Supplementary Text, Section I). In general, the regulation of the genes included in
these functional classes did not reveal any spatial specificity. H-RasV12 signals generated at
the plasma-membrane or at endomembranes were equally effective (Fig. 1D). Furthermore, in
general, most gene functional groups were represented in similar proportions in the different
compartment-specific transcriptomes (Fig. 1E).
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3.2. Singularities of Ras site-specific transcriptomes
We next evaluated the possible transcriptomal specificities of the site-specific Ras mutants.
Within the PM, it was observed that the DM-localized H-RasV12 protein (CD8) modulated a
total of 858 genes (504 up-regulated, 354 down-regulated) (Fig. 2A, see also Supplementary
Table S1). Furthermore, this subsignal contained the greatest number of specific genes of all
the H-RasV12 signals studied (108 genes, 90 up-regulated, 18 down-regulated) (Fig. 2B and
Table 1). Genes in this category include loci important for proliferation and survival such as
TRAF1, RASSF1 and c-Myc. A significant number of angiogenesis-related genes were also
detected in this DM-specific transcriptome (see Supplementary Text, Section II). The DM-
specific transcriptome was further characterized using Ingenuity (www.ingenuity.com), a web-
based software that identifies molecular networks by relating each microarray gene entry with
an extensive database of reported physical, transcriptional or enzymatic interactions for ≈ 8000
mouse proteins. This analysis revealed the existence of four main interactive networks radiating
from the nuclear proteins c-Myc, NFκB, c-Jun and HIF-1 (Fig. 2C). Keeping our focus on the
events unfolding from the PM, we analyzed the genetic profile emerging from Ras activation
at lipid rafts (LCK). This sublocalization regulated the lowest number of genes, barely 442
(189 up-regulated, 253 down-regulated) (Fig. 2A and Supplementary Table S1). Most
interestingly, not a single gene was specifically regulated from this compartment (Fig. 2B). In
addition to the genes that exhibited specific regulation from each of these PM sublocalizations,
another 13 genes could be regulated from either compartment. Of these, 3 were up-regulated,
3 down-regulated and 6 genes showed opposite regulation, among them the transcription factor
Ets2 (Fig. 2B, Supplementary Table S2). Overall, our analyses unveiled that 121 genes were
specifically regulated by Ras signals emanating from PM microdomains.
Interestingly, it was observed that ER-localized H-RasV12 (M1) induced the largest effect in
the cell transcriptome (438 up-regulated, 486 down-regulated, Appendix A). The analysis of
this transcriptome using the Ingenuity program revealed an interactive network nucleated
around the proteins p53, NFκB, c-Jun, Caspase-3 and cEBP (Fig. 2D), a result that is in
agreement with previous results indicating the implication of ER-specific H-RasV12 signaling
in cell survival and apoptosis. The analysis of the transcriptome of Golgi-localized H-RasV12
(KDEL) indicated a deregulation of 669 genes (317 up-regulated, 352 down-regulated) (Fig.
2A). Of those, only 4 genes exhibited a Golgi-specific regulation (Table 2). One of those loci
encoded the tyrosine phosphatase receptor κ (PTPκ), a putative tumor suppressor gene [17].
Three additional genes were shared by the ER- and Golgi-dependent H-RasV12 transcriptomes
(Fig. 2B, Supplementary Table S2). Taken together, these results indicate that H-RasV12, when
located in endomembranes, promotes a very small fraction of specific transcriptomal changes
(9 genes).
As comparative control, we included in our studies a cell line expressing untethered H-RasV12
(V12). The transcriptomal changes induced by this “ubiquitously localized” H-RasV12 protein
included a total of 699 genes (Fig. 2A). 51 of those genes were specifically regulated by this
H-Ras version and not shared by the site-specific H-Ras GTPases (Fig. 2B). The gene for
Caveolin-1, exhibiting a pronounced down-regulation, was among them (Table 3). In addition,
a number of loci deregulated by untethered H-RasV12 were shared with the transcriptomes of
other site-specific H-Ras proteins. For example, 61 genes were shared between untethered and
DM-localized H-RasV12 GTPases. Remarkably, 28 of those genes exhibited an antagonistic
regulation by these two proteins. Untethered H-RasV12 also deregulated 16 genes that were
also targeted by Golgi-localized H-RasV12, 13 of those genes displayed opposite regulation
(Fig. 2B Supplementary Table S2) (see Supplementary Text, Section II). Overall, these results
clearly indicate that the subcellular localization heavily conditions the genetic program
orchestrated by H-RasV12 in mouse fibroblasts.
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3.3. Identification of participants in Ras-induced transformation
Finally, we utilized the information obtained from the site-specific Ras genetic profiles, to
acquire further insights into the process of cellular transformation. Our previous studies have
revealed that the signals generated by RasV12 at lipid rafts, DM and ER induced
transformation, whereas signals from the Golgi did not [14]. Thus, we reasoned that the
elements in common among the transcriptomes resulting from transforming signals should be
of special relevance for the upbringing of malignant growth. We found that only 31 genes were
common to Ras transforming signals. 14 genes were down-regulated, including those encoding
Connective Tissue Growth Factor (CTGF), PDGF receptor β and DLK1. 17 genes were up-
regulated (For example, Epiregulin, R-PTPε, STK2/SLK, WIP and p120-GAP (Table 4). Many
of these proteins have been previously linked to cellular transformation and/or malignant
processes (see Supplementary Text, Section III).
The gene encoding for Vitamin D receptor (VDR) was one of the down-regulated genes shared
by all Ras transforming signals, so we tested the relevance of its attenuated expression for
transformation. By RT-PCR, we verified that VDR mRNA levels were markedly diminished
in cells expressing transforming RasV12 constructs, even to greater levels than those revealed
by the chips (Fig. 3A). Next, we tested whether increasing the levels of VDR could impact on
Ras transforming potential. To this end, we assayed the ability of the site-specific RasV12
proteins to generate foci in NIH3T3 cells when cotransfected with ectopic VDR. It was found
that VDR significantly diminished Ras-induced transformation. Interestingly, VDR inhibitory
effect varied depending on the site from which the Ras transforming signal emanated. Whereas
VDR abrogated transformation by lipid raft-targeted H-RasV12 almost completely, its negative
effects on the transformation induced by RasV12 at the ER or at DM were modest, ranging
between 25% and 30% (Fig. 3B). p120-GAP emerged as one of the up-regulated genes common
to the Ras transforming signals. We confirmed by immunoblotting that this was indeed the
case (Fig. 3C) and then tested the necessity for p120-GAP overexpression in Ras-induced
transformation. Cotransfection of ectopic p120-GAP with the site-specific H-RasV12
constructs enhanced the number of transformed foci in all cases (Fig. 3D). This demonstrated
that p120-GAP overexpression facilitated RasV12-induced transformation.
4. Discussion
We have used Affymetrix microarrays to acquire a genome-wide view of the gene expression
profiles induced by site-specific Ras signals in murine NIH3T3 fibroblasts, the level of overlap
among them and the singularities of the genetic outputs resulting from Ras activation at the
different membrane compartments where it resides. We have applied highly stringent and
restrictive parameters of significance for the processing and selection of the data and we have
utilized algorithms that allowed us to minimize the background noise and to maximize the
statistical significance of the data. Our results show that H-RasV12 signals regulate the
expression of 1074 genes in total. A figure of similar magnitude to those documented for
homologous models such as rat fibroblasts (1257 genes) [3] and MEFs (815 genes) [8].
Qualitative and quantitative analyses of the transcriptomal patterns resulting from site-specific
Ras activations, unveil that, in general, there is a significant overlap among the genetic
programs orchestrated from the different Ras compartments. Most genes could be regulated
from several localizations. Furthermore, the regulation of 329 genes, nearly a third, including
many genes essential for proliferation and survival, was common to all Ras compartments. Our
analysis showing that the functional classes in which the genes were grouped, are represented
to similar extents in all the transcriptomes, further highlighting the genotypic overlap among
the different Ras signals.
On the other hand, our results also confirm the presence of unique transcriptomal signatures
associated to each of the sublocalization-specific Ras signals. The signal generated at the DM
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is the one that controls the greatest number of genes specifically. Interestingly, 98% of these
genes exhibit up-regulation. The cellular functions and biological outputs specifically
orchestrated by Ras from the DM are unknown, but the fact that other subsignals are equally
competent in the regulation of proliferation and transformation [14] suggests that the switch-
on of this unique genetic program would be largely unrelated to these events. Interestingly, a
significant proportion of the DM-specific genes are involved in angiogenesis. Contrarily to
DM, the transcriptomal profile regulated by Ras at lipid rafts is the least numerous, since it
deregulated a total number of 442 genes. Most interestingly, not a single gene is specifically
regulated from this sublocalization. This observation is in full agreement and provides a
plausible explanation for the fact that H-Ras/N-Ras double knock-out mice, completely devoid
of Ras isoforms at lipid rafts, are viable and exhibit a normal phenotype [14,18].
Our results demonstrate that the total number of genes regulated by Ras from endomembranes
and from PM sublocalizations is similar. Furthermore, all the functional classes were regulated
alike by the endomembrane and the PM-localized Ras pools. Contrarily, there are dramatic
differences regarding the number of genes specifically regulated from the inner and outer
membrane systems: whereas 121 genes are exclusively regulated by Ras at the PM, only 9
genes are distinctive for Ras endomembrane signals. This result, however, should not lead to
the assumption that Ras endomembrane signals are less important. Our previous results have
demonstrated that Ras signals emanating from the ER are unique in their role of generating
antiapoptotic responses [14]. The only two genes specifically regulated by ER signals, Spg1
and SMAP1, are associated with severe medical conditions, but they show no evident
connection with cell survival. A deeper analysis of the ER transcriptome with the Ingenuity
program has unveiled the regulation of a complex network of genes functionally related to
apoptosis and survival. Thus, it is conceivable that not only qualitative changes, but also
quantitative differences, even small ones, in the regulation of common genes, can account for
abrupt variations in biological outputs.
From the Golgi, H-RasV12 is incapable of generating transforming signals [14]. Only four
genes are specifically regulated from this compartment, including R-PTPκ . This locus is
frequently deleted in tumors and has been attributed a putative tumor suppressor function
[17]. R-PTPκ down-modulates the EGFr and the β-catenin pathways, essential for cellular
proliferation and transformation [19,20]. Thus, one possibility is that the inability of Ras Golgi
signals for inducing transformation is a consequence of the up-regulation of R-PTPκ . Another
possibility is that Ras at the Golgi cannot regulate genes essential for transformation. In this
respect, we have identified 31 genes exclusive for the transforming signals emanating from
different Ras pools. Many of these genes have been previously linked to cellular transformation
and/or malignant processes (see Supplementary Text, Section III).
We have analyzed in further depth the role in transformation of two of these genes. The VDR
gene is down-regulated by Ras transforming signals, in agreement with previous studies
reporting the instability of VDR mRNA in Ras-transformed cells [21]. We demonstrate that
overexpression of VDR can abrogate Ras-induced transformation. Similar effects have been
shown for other nuclear receptors, such as the thyroid hormone receptor [22]. Interestingly,
the effect of VDR is dependent on localization: whereas VDR blocks the transformation
induced by lipid rafts signals almost completely, its effects on the transformation orchestrated
from DM are modest. The mechanisms underlying in these sublocalization-related effects are
completely unknown. Surprisingly, the gene encoding for p120-GAP is up-regulated by Ras
transforming signals. We demonstrate that p120-GAP over-expression enhances RasV12-
induced transformation. It is known that the loss of wild-type Ras alleles promotes
transformation by oncogenic Ras [23-25]. Thus, it can be envisioned that the upregulation
p120-GAP could achieve similar suppressive effects over wild-type Ras putative antioncogenic
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effects. Alternatively, it is possible that RasGAP could play some GAP-independent effector
functions in the Ras pathway.
We included in our studies “untargeted” H-RasV12 as a reference. Theoretically, the
transcriptome resulting from “global” Ras activation should be similar to the sum of the site-
specific gene profiles. However, it must be noticed that: a) The targeted Ras proteins are fixed
to their compartments, whereas untargeted Ras is free to translocate between localizations and
the cytoplasm [26]. This could cause differences in signal intensities and therefore impact on
the resulting transcriptomes. b) Some genes are regulated antagonistically from different
localizations. Thus, they could be under-represented or even absent in the “global” Ras
transcriptome. c) Our targeted Ras constructs do not cover all the possible Ras localizations.
Ras is also present in mitochondria [27,28], endosomes [13] and it cannot be discarded that
also at PM and endomembrane microdomains that escape the tethers used herein. Our analyses
identify 51 genes uniquely regulated by untargeted Ras. Maybe these genes are regulated from
sublocalizations undisclosed by our tethered Ras constructs. Alternatively, their regulation
could require the input from several sublocalizations. Thus, they would be silent under the
single signals generated by our targeted proteins.
Overall, our analyses demonstrate that although there is significant overlapping among the
transcriptomes resulting from Ras site-specific signals, there also exists a defined genetic
signature on the transcriptional events regulated by Ras from each of its localizations. This
adds further support to the notion of the subcellular microenvironment as a key regulator of
Ras functions at all levels. As such, physiological and pathological conditions that affect Ras
subcellular distribution, for example by altering the composition of cellular membranes, or by
shifting Ras palmitoylation/depalmitoylation balance, can have a profound impact on the
genetic program switched-on by Ras and thereby on the resultant biological outcomes. Thus
far, the biological functions regulated by each of the Ras subsignals are largely unknown and
under current investigation.
5. Conclusions
1. Using micro-array technology, we have identified the transcriptional program of the
conventional H-RasV12 oncoprotein as well as of versions of H-RasV12 that have
been placed in specific subcellular compartments (lipid rafts, disordered plasma
membrane, endoplasmic reticulum and Golgi apparatus) via the attachment of
subcellular localization targeting signals.
2. We have found that, although sharing a significant overlap in their respective
transcriptomes, the different subcellular localizations of H-RasV12 are linked to the
engagement of specific transcriptional programs.
3. Disordered membrane-localized H-Ras elicits the largest pool of specifically
regulated genes when compared to the rest of H-RasV12 mutants used. Instead, lipid
raff-localized H-RasV12 does not trigger any specific gene.
4. Plasma-membrane and endomembrane-localized H-RasV12 proteins trigger
specifically a total number of 121 and 9 genes, respectively.
5. By comparing the transcriptomes of transforming and non-transforming H-RasV12
mutants, we have identified 31 genes that are distinctively associated to the cell
transformation program. The involvement of two of those transformation-associated
genes in H-RasV12 transformation was demonstrated using cell biology techniques.
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Appendix A. Supplementary data
Supplementary data associated with this article can be found, in the online version, at 10.1016/
j.cellsig.2007.06.025.
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Fig. 1. Global analysis of Ras site-specific transcriptomes
A) Hierarchical clustering of the genes regulated by site-specific Ras proteins: untagged H-
RasV12 (V12) and ER- (M1), lipid raft- (LCK), DM- (CD8) and Golgi-tethered (KDEL) H-
RasV12 proteins. Horizontal rows represent single gene probe sets. Vertical columns represent
single microarray hybridizations. B) Histogram showing the number of up- (red) and down-
regulated (blue) genes with a given expression fold change value compared to that of the
parental cell line. Classifications of the genes according to general biological functions: C)
Total number of genes, up- (red) and down-regulated (blue). D) Number of genes regulated
from PM sublocalizations (LCK+CD8) and from endomembranes microdo-mains (M1
+KDEL). E) Number of genes regulated from each of the Ras sublocalizations. (For
interpretation of the references to colour in this figure legend, the reader is referred to the web
version of this article.)
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Fig. 2. Singularities of Ras site-specific H-RasV12 transcriptomes
A) Total number of genes in the site-specific Ras transcriptomes. up- (red), down-regulated
(blue). B) Quantification of the specific genes present in each of the Ras site-specific
transcriptomes and of those specific for double combinations of transcriptomes. C) Functional
networks in the disordered membrane Ras transcriptome identified using the Ingenuity
database. Nodes are color-coded in red (up-regulated) or green (down-regulated) according to
their fold change values. D) Functional network related to survival and apoptosis present in
the Ras ER-signal transcriptome, identified using the Ingenuity database. (For interpretation
of the references to colour in this figure legend, the reader is referred to the web version of this
article.)
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Fig. 3. Identification of participants in Ras-induced transformation
A) RT-PCR determination of the VDR mRNA expression levels in the parental control (c) and
in cell lines expressing the indicated site-specific H-RasV12 constructs. Bars show average
±SEM of three independent experiments. Figures show the expression levels relative to those
in the parental cell line. B) VDR overexpression impairs Ras-induced transformation. Number
of transformed foci in NIH3T3 cells transfected with the Ras constructs, plus either an empty
vector or with a VDR-encoding plasmid. C) p120-GAP expression is up-regulated by Ras
transforming signals. P120-GAP expression levels in parental (c) and the cell lines expressing
the site-specific Ras constructs. Immunoblotting for ERK is shown as a loading control. Figures
show the levels of expression relative to those in the parental cell line (c), in the immunoblots
and those revealed by the gene arrays. D) p120-GAP overexpression potentiates Ras-induced
transformation. Number of transformed foci in NIH3T3 cells transfected with the Ras
constructs plus vector or a p120-GAP expressing construct. B and E) Bars show average±SEM
of five independent experiments.
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Table 1
Genes specifically regulated from Disordered Membrane (CD8)
ID probe set R-fold Gene symbol Functional class Gene name
Growth factor
103520_at 2.64 Vegfa Vascular endothelial growth factor A
102624_at 2.07 Stc2 Stanniocalcin 2
92578_at 1.76 Scye1 Small inducible cytokine figure2dsubfamily E, member 1
Signal transduction
101441_i_at 4.28 Itpr5 Inositol 1,4,5-triphosphate receptor 5
102379_at 2.47 Rassf1 Ras association (RalGDS/AF-6) domain family 1
93116_at 2.37 Prkacb Protein kinase, cAMP dependent, catalytic, beta
100014_at 2.34 Tlk2 Tousled-like kinase 2
97740_at 2.18 Dusp16 Dual specificity phosphatase 16
94186_at 2.18 Traf1 Tnf receptor-associated factor 1
101937_s_a 1.72 Clk4 CDC like kinase 4
94394_at 1.63 Rras Harvey rat sarcoma oncogene, subgroup R
160876_at 1.47 Bcap29 B-cell receptor-associated protein 29
Regulation of transcription
104712_at 3.64 Myc Myelocytomatosis oncogene
97893_at 2.81 Tbpl1 TATA box binding protein-like 1
101902_at 2.8 Rbpsuh Recombining binding protein suppressor of hairless
101995_at 2.55 Sqstm1 Sequestosome 1
160535_at 2.42 Nfe2l1 Nuclear factor, erythroid derived 2,-like 1
93697_at 2.07 Cbx4 Chromobox homolog 4
(Drosophila Pc class)
104215_at 1.89 Atf6 Activating transcription factor 6
95521_s_at 1.64 Zfp68 Zinc finger protein 68
103006_at 1.51 Atf5 Activating transcription factor 5
101958_f_at 0.53 Tfdp1 Transcription factor Dp 1
101959_r_at 0.53 Tfdp1 Transcription factor Dp 2
100307_at 0.51 Nfix Nuclear factor I/X
95791_s_at 0.43 Sfrs2 Splicing factor, arginine/serine-rich 2
99607_at 0.39 Skp1a S-phase kinase-associated protein 1A
DNA replication
104096_at 2.37 Orc4l origin recognition complex subunit 4
Cell cycle
101429_at 9 Ddit3 DNA-damage inducible transcript 3
Cytoskeleton
103330_at 2.22 Spnr Spermatid perinuclear RNA-binding protein
101578_f_at 0.58 Actb Actin, beta, cytoplasmic
160462_f_at 0.49 Tubb3 Tubulin, beta 3
100342_i_at 0.48 Tuba1 Tubulin, alpha 1
Protein biosynthesis
104144_at 3.34 Gtpbp2 GTP binding protein 2
98936_at 2.74 Sars1 Seryl-aminoacyl-tRNA synthetase 1
93564_at 2.69 Yars Tyrosyl-tRNA synthetase
93270_at 2.55 Gars Glycyl-tRNA synthetase
103630_at 2.54 Lars Leucyl-tRNA synthetase
96693_at 2.5 Rars Arginyl-tRNA synthetase
94494_at 2.41 Farsl Phenylalanine-tRNA synthetase-like, beta subunit
93752_at 2.38 E430001P04Rik Isoleucine-tRNA synthetase
95054_at 2.35 Tars Threonyl-tRNA synthetase
98605_at 2.16 Wars Tryptophanyl-tRNA synthetase
94484_at 1.97 Hbs1l Hbs1-like
Protein biosynthesis
95159_at 1.91 Mrps18b Mitochondrial ribosomal protein S18B
95067_at 1.52 Mrpl2 Mitochondrial ribosomal protein L2
Proteol and peptidolysis
160328_at 4.18 Prss15 Protease, serine, 15
96920_at 2.1 Prss11 Protease, serine, 11 (Igf binding)
98906_at 0.41 Fbxo9 f-box only protein 9
Metabolism
161221_f_at 3.11 Asns Asparagine synthetase
95738_at 2.82 Pycs Pyrroline-5-carboxylate synthetase
94369_at 2.19 Gnpnat1 Glucosamine-phosphate N-acetyltransferase 1
160647_at 2.15 Car6 Carbonic anhydrase 6
104343_f_at 2.13 Pla2g12 Phospholipase A2, group XIIA
97560_at 2.01 Psap Prosaposin
160770_at 0.53 Mvd Mevalonate (diphospho) decarboxylase
94325_at 0.26 Hmgcs1 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1
Transport
104221_at 3.4 Slc7a5 Solute carrier family 7 (cationic amino acid transporter, y+ system),
member 5
96160_at 2.73 Slc6a9 Solute carrier family 6 (neurotransmitter transporter, glycine), member
9
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ID probe set R-fold Gene symbol Functional class Gene name
92648_at 2.24 Stxbp3 Syntaxin binding protein 3
92582_at 1.91 Slc1a7 Solute carrier family 1 (neutral amino acid transporter), member 5
104706_at 1.55 Pex7 Peroxisome biogenesis factor 7
Electron transport
92587_at 2.17 Fdx1 Ferredoxin 1
93844_at 1.74 Qpc-pending Ubiquinol-cytochrome c reductase binding protein
Ion transport
102786_at 2.11 Clcn3 Chloride channel 3
104704_at 0.45 Clcn4-2 Chloride channel 4-2
Apoptosis
160412_at 2.41 Pdcd2 Programmed cell death 2
Other
97914_at 2.88 Hspa9a Heat shock protein, A
94643_at 2.25 Taa1 Poliovirus receptor
160530_at 2.12 Ghitm Growth hormone inducible transmembrane protein
104033_at 2.1 Mgea6 Meningioma expressed antigen 6
98451_at 1.94 Dnajb10 DnaJ (Hsp40) homolog, subfamily B, member 10
160230_at 1.94 Cox17 Cytochrome c oxidase, subunit XVII assembly protein homolog (yeast)
97269_f_at 1.91 Kcp2-pending Keratinocytes associated protein 3
160176_at 1.86 Hirip5 Histone cell cycle regulation defective interacting protein 5
93385_at 1.84 Nthl1 nth (endonuclease III)-like 1
97268_i_at 1.78 Kcp2-pending Keratinocytes associated protein 2
101947_at 1.77 Nakap95-pending A kinase (PRKA) anchor protein 8-like
160092_at 1.71 Ifrd1 Interferon-related developmental regulator 1
95109_at 1.67 Nol5a Nucleolar protein 5A
Other
97204_s_at 1.61 Dnajd1 DnaJ (Hsp40) homolog, subfamily D, member 1
94346_at 1.61 Wtap Wilms’ tumour 1-associating protein
94455_at 0.59 Lsm3 LSM3 homolog, U6 small nuclear RNA associated
96254_at 0.51 Dnajb1 DnaJ (Hsp40) homolog, subfamily B, member 1
103598_at 0.46 Dhx9 DEAH (Asp-Glu-Ala-His) box polypeptide 9
Unknown
104116_at 11.8 D5Ertd593e Unknown
104363_at 2.75 AI747712 Unknown
103739_at 2.68 1110017N23Rik Unknown
94340_at 2.62 1110004L07Rik Unknown
95636_at 2.34 0610010K14Rik Unknown
96539_at 2.31 9330147J08Rik Unknown
104513_at 2.28 2410004N09Rik Unknown
95634_at 2.07 0610010K14Rik Unknown
103773_at 2.27 1110020K19Rik Unknown
97919_at 2.12 1110021E09Rik Unknown
160279_at 2.01 AA408582 Unknown
97118_at 1.95 AI159700 Unknown
98089_at 1.88 1190005P17Rik Unknown
102056_f_at 1.83 2610002J02Rik Unknown
97308_at 1.71 5730466P16Rik Unknown
94366_at 1.7 2310079N02Rik Unknown
95592_at 1.6 1110019N10Rik Unknown
103312_f_at 1.56 C79684 Unknown
104045_at 1.53 2610102M01Rik Unknown
94830_at 0.5 8030460C05Rik Unknown
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Table 2
Genes specifically regulated from Golgi complex (KDEL) and from Endoplasmic Reticulum (M1) Endoplasmic
Reticulum (M1)
ID probe set R-fold Gene symbol Functional class Gene name
KDEL
Signal transduction
160760_at 1.8 Ptprk Protein tyrosine phosphatase, receptor type, K
Apoptosis
95094_g_at 1.75 Ccar1 Cell division cycle and apoptosis regulator 1
Other
102712_at 3.47 Saa3 Serum amyloid A 3
Unknown
100073_at 1.63 2510005D08Rik Unknown
M1
Metabolism
95430_f_at 0.67 Spg21 Spastic paraplegia 21 homolog
Other
160196_at 0.66 Smap1 Stromal membrane-associated protein 1
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Table 3
Genes specifically regulated by ubiquitous H-RasV12
ID probe set R-fold Gene symbol Functional class Gene name
Cell adhesion
160319_at 2.7 Sparcl1 SPARC-like 1 (mast9, hevin)
101110_at 2.47 Col6a3 Procollagen, type VI, alpha 3
95661_at 2.19 Cd9 CD9 antigen
162193_f_at 2.13 Itgb7 Integrin beta 7
95706_at 1.73 Lgals3 Lectin, galactose binding, soluble 3
98331_at 0.55 Col3a1 Procollagen, type III, alpha 1
100153_at 0.36 Ncam1 Neural cell adhesion molecule 1
Regulation of transcription
102867_at 2.23 Tead4 TEA domain family member 4
104701_at 1.83 Bhlhb2 Basic helix-loop-helix domain containing, class B2
93008_at 0.55 Lsm4 LSM4 homolog, U6 small nuclear RNA associated
95049_at 0.55 Snrpd2 Small nuclear ribonucleoprotein D2
96711_at 0.49 Znrd1 Zinc ribbon domain containing, 1
Cytoskeleton
160417_at 1.73 Kif5b Kinesin family member 5B
Protein biosynthesis
92628_at 0.48 Rpl36 Ribosomal protein L36
Proteol and peptidolysis
96061_at 1.97 Usp14 Ubiquitin specific protease 14
Metabolism
96790_f_at 2.38 Galm Galactose mutarotase
103392_at 2.34 Adcy7 Adenylate cyclase 7
95758_at 2.12 Scd2 Stearoyl-Coenzyme A desaturase 2
160737_at 2.02 Lss Lanosterol synthase
98931_at 1.82 Gns Glucosamine (N-acetyl)-6-sulfatase
102381_at 1.74 Acsl4 Acyl-CoA synthetase long-chain family member 4
94276_at 1.7 Hsd17b12 Hydroxysteroid (17-beta) dehydrogenase 12 protein
99148_at 0.63 Fh1 Fumarate hydratase 1
93984_at 0.6 Atpi ATPase inhibitor
97907_at 0.56 Lsm7 LSM7 homolog, U6 small nuclear RNA associated
101084_f_at 0.55 Dpm3 Dolichyl-phosphate mannosyltransferase polypeptide 3
101990_at 0.46 Ldh2 Lactate dehydrogenase 2, B chain
Transport
93738_at 2.6 Slc2a1 Solute carrier family 2 (facilitated glucose transporter), member 1
95625_at 2.36 Slc6a8 Solute carrier family 6 (neurotransmitter transporter, creatine),
member 8
94807_at 1.92 Slc25a1 Solute carrier family 25, member 1
104565_at 0.48 Ap4s1 Adaptor-related protein complex AP-4, sigma 1
160280_at 0.44 Cav Caveolin, caveolae protein
Ion transport
102861_at 4.92 Slc22a1l Solute carrier family 22 (organic cation transporter), member 18
160529_r_at 1.93 Vdac2 Voltage-dependent anion channel 2
103459_at 1.83 Slc39a6 Solute carrier family 39 (metal ion transporter), member 6
Proton transport
160202_at 2.74 Atp6ip2 ATPase, H+ transporting, lysosomal accessory protein 2
95745_g_at 2.05 Atp6v1a1 ATPase, H+ transporting, V1 subunit A, isoform 1
Other
98045_s_at 3.17 Dab2 Disabled homolog 2
92802_s_at 2.07 Plp Proteolipid protein (myelin)
95456_r_at 0.6 Shfdg1 Split hand/foot deleted gene 1
160550_i_at 0.59 Magoh Mago-nashi homolog, proliferation-associated
96004_at 0.58 Sri Sorcin
98992_at 0.55 Eppb9 Endothelial precursor protein B9
104078_g_at 0.51 Eso3 Eso3 protein
Unknown
100477_at 2.7 C630002M10Rik Unknown
95288_i_at 1.87 C330012F17Rik Unknown
160569_at 0.51 2310008M10Rik Unknown
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